IRIS UniCatt

Navarra, Pierluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.429
EU - Europa 8.322
AS - Asia 5.626
SA - Sud America 1.164
AF - Africa 123
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.185
SG - Singapore 2.597
DE - Germania 2.510
IT - Italia 1.392
CN - Cina 1.366
PL - Polonia 1.158
BR - Brasile 947
SE - Svezia 910
FR - Francia 565
VN - Vietnam 513
UA - Ucraina 478
GB - Regno Unito 367
IN - India 262
IE - Irlanda 251
FI - Finlandia 206
ID - Indonesia 165
RU - Federazione Russa 135
HK - Hong Kong 125
JP - Giappone 118
CA - Canada 105
TR - Turchia 92
NL - Olanda 85
MX - Messico 80
AR - Argentina 78
BD - Bangladesh 67
IQ - Iraq 60
ES - Italia 55
BE - Belgio 48
ZA - Sudafrica 41
EC - Ecuador 37
AT - Austria 29
CL - Cile 27
KR - Corea 25
SA - Arabia Saudita 25
VE - Venezuela 22
IR - Iran 21
CH - Svizzera 20
UZ - Uzbekistan 20
AU - Australia 19
MA - Marocco 19
PK - Pakistan 19
CZ - Repubblica Ceca 17
CO - Colombia 16
LT - Lituania 16
KE - Kenya 15
AZ - Azerbaigian 14
TT - Trinidad e Tobago 14
PH - Filippine 13
IL - Israele 12
KZ - Kazakistan 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
PE - Perù 11
BO - Bolivia 10
GR - Grecia 10
JO - Giordania 10
JM - Giamaica 9
RO - Romania 9
HU - Ungheria 8
OM - Oman 8
PY - Paraguay 8
BG - Bulgaria 7
HN - Honduras 7
LV - Lettonia 7
TH - Thailandia 7
TN - Tunisia 7
UY - Uruguay 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
LB - Libano 6
NP - Nepal 6
PA - Panama 6
PT - Portogallo 6
DK - Danimarca 5
ET - Etiopia 5
GE - Georgia 5
MD - Moldavia 5
CR - Costa Rica 4
NO - Norvegia 4
TW - Taiwan 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
DZ - Algeria 3
KG - Kirghizistan 3
KW - Kuwait 3
MN - Mongolia 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
EU - Europa 2
Totale 24.652
Salva come PNG Salva come JPEG
Città #
Singapore 1.322
Chandler 1.197
Ashburn 1.093
Warsaw 1.057
San Jose 822
Jacksonville 317
San Mateo 273
Dublin 251
Beijing 249
New York 244
Wilmington 230
Fairfield 229
Verona 225
Milan 219
Houston 201
Nanjing 201
Rome 198
Los Angeles 194
Ann Arbor 181
Chicago 179
Ho Chi Minh City 172
Woodbridge 156
Jakarta 151
Lauterbourg 147
Nürnberg 144
Cattolica 141
Seattle 141
Bremen 127
Munich 125
Hefei 113
Hong Kong 112
Dearborn 110
Hanoi 107
Dallas 106
The Dalles 104
Tokyo 100
Boston 95
São Paulo 92
Cambridge 89
Buffalo 88
Kraków 88
Frankfurt am Main 87
Moscow 86
Lawrence 84
Council Bluffs 83
Helsinki 83
Nanchang 80
Marseille 77
Redwood City 66
Santa Clara 60
Princeton 56
Izmir 49
London 47
Brussels 46
Boardman 44
Salt Lake City 44
Lancaster 43
Mountain View 42
Phoenix 38
Paris 37
Hangzhou 36
Kunming 36
Orem 36
Nuremberg 34
North Bergen 33
Shenyang 33
Tianjin 32
University Park 32
Toronto 31
Jiaxing 30
Pune 30
Atlanta 29
Leawood 29
Fremont 28
Hyderabad 28
Rio de Janeiro 28
Brooklyn 27
Chennai 27
Düsseldorf 27
Denver 26
Guangzhou 25
Shanghai 25
Changsha 24
Da Nang 24
Philadelphia 24
Stockholm 24
Belo Horizonte 23
Hebei 23
Kent 23
Baghdad 22
Montreal 22
Redmond 21
Amsterdam 20
Brasília 20
Haiphong 20
Lappeenranta 20
Mexico City 20
Salvador 20
Falkenstein 19
Memphis 19
Totale 13.592
Salva come PNG Salva come JPEG
Nome #
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 495
The human microglial HMC3 cell line: where do we stand? A systematic literature review 469
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 441
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 439
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 425
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 422
mTOR kinase: a possible pharmacological target in the management of chronic pain 409
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 386
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of BCL-XL gene expression. 376
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 366
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 319
Effects of remifentanil on human C20 microglial pro-inflammatory activation 283
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 269
The role of small intestinal bacterial overgrowth in Parkinson's disease 251
Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapanisertib 246
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 242
Full HTA di Emicizumab 236
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 230
Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells 230
Antiretrovirals inhibit arginase in human microglia 218
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 217
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 209
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature 205
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 204
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 201
Produzione in vitro e in vivo di interleuchina-1 dopo una convulsione febbrile 198
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. 194
Variability of raltegravir plasma levels in the clinical setting 192
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 192
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 189
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 188
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 188
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 186
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 185
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 184
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 180
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 178
N-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. 176
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 173
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 173
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 173
Antiretrovirals inhibit arginase in human microglia 171
Pro-inflammatory activation of a new immortalized human microglia cell line 169
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 169
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 168
Utilizzo degli antidepressivi e caratteristiche socio-economiche nelle regioni italiane. Evidenze da uno studio ecologico. 168
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis 168
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 167
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 165
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 164
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 162
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. 160
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 160
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 157
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 157
beta-Carotene Downregulates the Steady-State and Heregulin-{alpha}-Induced COX-2 Pathways in Colon Cancer Cells. 154
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 154
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 154
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 153
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 151
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 151
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 150
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers 148
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 148
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 148
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. 147
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay 147
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 147
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 146
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 145
Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol. 145
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 145
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 145
Molecular and pharmacological evidence for a facilitatory functional role of presynaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus. 145
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 144
Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat 144
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 144
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 144
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 144
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. 142
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 141
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 140
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 139
P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals 139
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 138
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 137
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer 137
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 134
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 132
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 130
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB 130
Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies 130
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 129
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 127
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 127
Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization 127
Exploiting microglial functions for the treatment of glioblastoma 127
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 127
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 126
Carbon monoxide as a novel neuroendocrine modulator: Inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants 126
Totale 19.370
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.715 150 112 26 102 121 65 42 236 71 96 428 266
2022/20233.095 359 451 239 522 239 367 115 265 342 48 93 55
2023/20241.633 90 396 66 153 81 219 119 55 30 58 182 184
2024/20253.380 77 88 225 121 259 136 60 177 546 302 920 469
2025/20267.889 1.050 246 504 908 1.294 379 1.449 348 551 589 287 284
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 24.966